PDF Version
To Publications Page
To Home Page

Archived on: September 1, 2011. This document may contain dated information. It remains available to provide access to historical materials.
This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been coordinated with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.
Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.
Figure 1. Philadelphia/Camden High Intensity Drug Trafficking Area
Table 1. Drug Seizures in the Philadelphia/Camden
HIDTA, in Kilograms, 2009
Table 2. Drug Distribution Activities in the
Philadelphia/Camden HIDTA, 2009
Cocaine (particularly crack) poses the principal drug threat in the Philadelphia/Camden High Intensity Drug Trafficking Area (PC HIDTA) region because of high levels of abuse and the violence attendant to street gang distribution of the drug. Heroin, marijuana, and controlled prescription drugs (CPDs) are also significant threats to the region.
The following are significant strategic drug threat developments in the PC HIDTA region:
National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622
Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov
Office of Policy and Interagency Affairs
U.S. Department of Justice
Robert F. Kennedy Building, Room 3341
950 Pennsylvania Avenue, NW
Washington, D.C. 20530-2000
Telephone: (202) 532-4040
FAX (202) 514-4252
ADNET: http://ndicosa.adnet.sgov.gov
DOJ: http://www.justice.gov/archive/ndic/
LEO: https://www.leo.gov/http/leowcs.leopriv.gov/lesig/archive/ndic/index.htm
RISS: ndic.riss.net
a. Benzodiazepines, hydrocodone, fentanyl, methadone, and oxycodone.
End of page.